MAGNOLIA NEUROSCIENCES

Magnolia Neurosciences aims to discover and develop proprietary, selective, and drug-like small molecule therapeutics for the prevention of neuronal cell death, thereby providing novel treatment options for patients suffering from neurodegeneration and related conditions. Magnolia Neurosciences Corporation, created to pursue technologies developed at The University of Texas MD Anderson Cancer Center’s Therapeutics Discovery Division and the Neurodegeneration Consortium (NDC), is a New York-based Accelerator Life Science Partner portfolio company.

#People #Financial #Website #More

MAGNOLIA NEUROSCIENCES

Industry:

Biotechnology Health Care Neuroscience Wellness

Founded:

2018-01-01

Address:

New York, New York, United States

Country:

United States

Website Url:

http://www.magnolianeurosciences.com

Total Employee:

Status:

Active

Contact:

646-828-5990

Email Addresses:

[email protected]

Total Funding:

49.39 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF WordPress Apache Wordpress Plugins Euro Microsoft Exchange Online Office 365 Mail Google Maps

Current Employees Featured

philip-jones_image

Philip Jones
Philip Jones Founder @ Magnolia NeuroSciences
Founder

thong-ngo_image

Thong Ngo
Thong Ngo Chief Executive Officer, President and Board Member @ Magnolia NeuroSciences
Chief Executive Officer, President and Board Member

Founder

philip-jones_image

Philip Jones

Investors List

md-anderson-cancer-center-19d6_image

Official Site Inspections

http://www.magnolianeurosciences.com Semrush global rank: 6.03 M Semrush visits lastest month: 1.35 K

Host Informations
Whois Informations

Loading ...